Comparisons of serum COMP levels to primary tumors and lymph node metastases (LNM) COMP IHC expression were not performed since the serum samples were obtained at diagnosis of metastatic disease and not at the initial breast cancer diagnosis. Here, COMP is linked to metastatic malignant neoplasm in the lymph nodes.